Live Breaking News & Updates on Upal Basu Roy

Stay updated with breaking news from Upal basu roy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Landmark' Findings Led to Alecensa Approval for ALK-Positive NSCLC

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer. ....

Upal Basu Roy , Drug Administration , Lungevity Foundation , New England Journal , Lung Cancer Treatment , Non Small Cell Lung Cancer ,

LUNGevity and RETpositive Issue RFA for Pan-Cancer Research Focused on RET Biomarker

LUNGevity and RETpositive Issue RFA for Pan-Cancer Research Focused on RET Biomarker
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Upal Basu Roy , Hilary Hammell , Prnewswire Lungevity Foundation , Lungevity Award Foundation , Lungevity Research , Charity Navigator , Source Lungevity Foundation , Lungevity Foundation , Retpositive Lungevity Translational Research Award , Translational Research Award , Basu Roy , Patient Gateways ,